Securities code: Zhuhai Rundu Pharmaceutical Co.Ltd(002923) securities abbreviation: Zhuhai Rundu Pharmaceutical Co.Ltd(002923) Announcement No.: 2022027
Zhuhai Rundu Pharmaceutical Co.Ltd(002923)
Announcement on holding 2021 annual performance briefing
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Zhuhai Rundu Pharmaceutical Co.Ltd(002923) (hereinafter referred to as “the company”) was posted on cninfo.com on April 20, 2022（ http://www.cn.info.com.cn./ ）The full text and summary of the company’s 2021 annual report were disclosed on the.
In order to facilitate the majority of investors to further understand the company’s operation in 2021, the company is scheduled to hold a 2021 annual performance presentation on panorama.com from 15:00 to 17:00 on May 6, 2022. This annual performance presentation will be held online. Investors can log in to panorama.com’s “investor relations interactive platform”（ http://ir.p5w.net. ）Participate in this annual performance briefing.
Present at the annual performance presentation meeting are: Mr. Chen Xinmin, chairman of the company, Mr. Liu Jie, Director / general manager, Mr. Yang Deming, independent director, Mr. Shi Shenhua, Chief Financial Officer / deputy general manager, and Mr. Zeng Yong, Secretary of the board of directors / deputy general manager.
Welcome investors to participate actively and sincerely thank investors for their concern and support for the development of the company. It is hereby announced.
Zhuhai Rundu Pharmaceutical Co.Ltd(002923) board of directors April 25, 2022
